We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





COVID-19 Playbook Leverages Advanced Analytics for Accelerating Vaccine Development and Drug Discovery

By HospiMedica International staff writers
Posted on 10 Apr 2020
Print article
Illustration
Illustration
Signals Analytics, Inc. (New York, NY, USA), the next-generation advanced analytics platform that leverages external data to uncover trends and predictive insights, has unveiled its COVID-19 Playbook, providing access to critical market intelligence and trends surrounding potential treatments for the novel coronavirus. As part of its dedication towards fighting the virus, Signals Analytics is offering the COVID-19 Playbook at no cost to researchers looking to monitor vaccines that are in development for COVID-19 and other strains of coronavirus; monitor trending drugs that are being tested for COVID-19; and assess which drugs are being repurposed to help treat infected people.

Signals Analytics is a next-generation advanced analytics configurable platform that extracts context from uncorrelated external data sources to uncover trends and predictive insights. Users of the platform include heads of innovation, R&D, growth, licensing and business development who incorporate Signals Analytics' market intelligence into their planning processes.

The COVID-19 Playbook is a front-end user interface of the Signals Analytics platform, powered by advanced analytics, patented Natural Language Processing (NLP) techniques and taxonomies developed by domain experts with years of academic and pharmaceutical industry experience. It connects data from a wide range of sources including clinical trials, research papers, business events, announcements, media coverage, drug developments and more. Context is extracted from the various data types and visualizations and actionable insights are generated. The COVID-19 Playbook includes dashboards such Drug Pipeline Overview, a COVID-19 Target and Modality Landscape, and Research Paper Assessment. In addition, users can set manual alerts through the Findings section to receive updates once per week.

Like Signals Analytics’ other playbooks, the COVID-19 Playbook is aimed at heads of research, development, and innovation as well as leaders responsible for growth, business development, mergers and acquisitions, looking for ways to speed up the vaccine and drug discovery process. The aggregated dashboards address many important business questions such as: what are the leading and emerging targets being analyzed for COVID-19, which are the leading and emerging drugs and vaccines that are being researched and tested, which drugs are being repurposed to treat COVID-19, and which entities are leading and emerging for COVID-19 testing and treatment.

“As the COVID-19 pandemic progresses, a deluge of data is being generated every day and it is impossible for researchers to keep up,” said Gil Sadeh, CEO of Signals Analytics. “Most other platforms provide insights based on limited data sets or simple reference listings that require the user to input specific search parameters. The Signals Analytics platform on the other hand is designed to surface trends and actionable insights across a wide range of data sets to alleviate the burden researchers and analysts face as they look for clues that will speed up vaccine development and identify effective treatments. In the middle of this pandemic, every minute counts. We are proud to offer our COVID-19 Playbook to industry leaders, non-profits and government agencies to turn a very labor-intensive process filled with risk and uncertainty into something actionable and relevant that will speed up the end to this scourge.”

Related Links:
Signals Analytics, Inc.

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Hospital Data Analytics Software
OR Companion
New
Electric Cast Saw
CC4 System

Print article

Channels

Surgical Techniques

view channel
Image: Schematic diagram of intra-articular pressure detection using a sensory system in a sheep model (Photo courtesy of Science China Press)

Novel Sensory System Enables Real-Time Intra-Articular Pressure Monitoring

Knee replacement surgery is a widely performed procedure to relieve knee pain and restore joint function, with over one million surgeries conducted annually. However, 10%-20% of patients remain dissatisfied... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.